315 related articles for article (PubMed ID: 2651753)
1. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.
Pruchno CJ; Burns MW; Schulze M; Johnson RJ; Baker PJ; Couser WG
Kidney Int; 1989 Jul; 36(1):65-71. PubMed ID: 2681928
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.
Pruchno CJ; Burns MM; Schulze M; Johnson RJ; Baker PJ; Alpers CE; Couser WG
Am J Pathol; 1991 Jan; 138(1):203-11. PubMed ID: 1987766
[TBL] [Abstract][Full Text] [Related]
4. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
Susani M; Schulze M; Exner M; Kerjaschki D
Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
[TBL] [Abstract][Full Text] [Related]
6. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).
Kerjaschki D; Neale TJ
J Am Soc Nephrol; 1996 Dec; 7(12):2518-26. PubMed ID: 8989729
[TBL] [Abstract][Full Text] [Related]
8. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG
Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
[TBL] [Abstract][Full Text] [Related]
9. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals.
Salant DJ; Darby C; Couser WG
J Clin Invest; 1980 Jul; 66(1):71-81. PubMed ID: 7400310
[TBL] [Abstract][Full Text] [Related]
10. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy.
Schulze M; Donadio JV; Pruchno CJ; Baker PJ; Johnson RJ; Stahl RA; Watkins S; Martin DC; Wurzner R; Gotze O
Kidney Int; 1991 Sep; 40(3):533-8. PubMed ID: 1787650
[TBL] [Abstract][Full Text] [Related]
11. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of terminal complement complex in active Heymann nephritis.
de Heer E; Daha MR; Bhakdi S; Bazin H; van Es LA
Kidney Int; 1985 Feb; 27(2):388-93. PubMed ID: 3886996
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of immune-deposit formation and the mediation of immune renal injury.
Nangaku M; Couser WG
Clin Exp Nephrol; 2005 Sep; 9(3):183-91. PubMed ID: 16189625
[TBL] [Abstract][Full Text] [Related]
14. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.
Spicer ST; Tran GT; Killingsworth MC; Carter N; Power DA; Paizis K; Boyd R; Hodgkinson SJ; Hall BM
J Immunol; 2007 Jul; 179(1):172-8. PubMed ID: 17579035
[TBL] [Abstract][Full Text] [Related]
15. Detection of terminal complement components in experimental immune glomerular injury.
Adler S; Baker PJ; Pritzl P; Couser WG
Kidney Int; 1984 Dec; 26(6):830-7. PubMed ID: 6241952
[TBL] [Abstract][Full Text] [Related]
16. Membrane attack complex deposition in experimental glomerular injury.
Perkinson DT; Baker PJ; Couser WG; Johnson RJ; Adler S
Am J Pathol; 1985 Jul; 120(1):121-8. PubMed ID: 3160245
[TBL] [Abstract][Full Text] [Related]
17. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.
Baker PJ; Ochi RF; Schulze M; Johnson RJ; Campbell C; Couser WG
Am J Pathol; 1989 Jul; 135(1):185-94. PubMed ID: 2672823
[TBL] [Abstract][Full Text] [Related]
18. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
Singh AK; Kasinath BS
Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.
Nakazawa M; Emancipator SN; Lamm ME
J Exp Med; 1986 Dec; 164(6):1973-87. PubMed ID: 3537193
[TBL] [Abstract][Full Text] [Related]
20. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.
Schulze M; Pruchno CJ; Burns M; Baker PJ; Johnson RJ; Couser WG
Am J Pathol; 1993 Jan; 142(1):179-87. PubMed ID: 7678717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
